Neurological Disorder Diagnostics Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-01-22　·　152 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 13.76 Bn
2033 年預估規模: USD 15.87 Bn
年複合成長率 CAGR: 9.1%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

出版商 Coherent Market Insights 產業別 Healthcare & Life Sciences出版日期 2026-01-22頁數 152報告編號 CMI1867

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Neurological Disorder Diagnostics Market, By Technology (Imaging, and In Vitro Diagnostics), By Disease Indication (Genetic Neurological Disorders, Immunological Neurological Disorders, Paraneoplastic Syndrome, Paraproteinemic Neuropathies, and Others), By End User (Hospitals & Clinics, Diagnostic Centers, and Ambulatory Care Centers), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

報告摘要

Neurological disorder diagnostic tools are used for the diagnosis of various neurological disorders such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease and others. Neurological disorders can be diagnosed with the use of imaging and in vitro diagnostic techniques. Imaging techniques such as computed tomography (CT) and magnetic resonance imaging (MRI) are used to create detailed images of organs, bones, soft tissue, blood vessels, and other parts of body. Whereas, in-vitro diagnostic techniques include biopsy, biomarker, blood test, urine test, and genetic testing. Market Dynamics Technological innovations and developments in neurological disorder diagnosing devices are expected to drive the market growth. For instance, in 2017, Neusoft Medical Systems developed an innovative CT scanner NeuViz Prime CT Scanner and received the U.S. Food and Drug Administration approval for the system. Moreover in 2016, Koninklijke Philips N.V. launched IQon Spectral CT in Canada. IQon Spectral CT is a spectral detector CT, designed specifically for spectral imaging. Key features of the study • This report provides in-depth analysis of the global neurological disorder diagnostics market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2019–2027), considering 2018 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global neurological disorder diagnostics market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans • Key companies covered as a part of this study include Siemens Healthineers, Koninklijke Philips N.V., General Electric Company, Esaote SpA, NeuroLogica Corporation, Masimo Corporation, York Instruments Ltd., Neusoft Medical Systems, and Canon Medical Systems Corporation • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future product launches, technology upgradation, market expansion, and marketing tactics • The global neurological disorder diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neurological disorder diagnostics market Market Segmentation • By Technology o Imaging o In Vitro Diagnostics • By Disease Indication o Genetic Neurological Disorders o Immunological Neurological Disorders o Paraneoplastic Syndrome o Paraproteinemic Neuropathies o Others • By End User o Hospitals & Clinics o Diagnostic Centers o Ambulatory Care Centers • By Regional Insights o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o Siemens Healthineers o Koninklijke Philips N.V. o General Electric Company o Esaote SpA o NeuroLogica Corporation o Masimo Corporation o York Instruments Ltd. o Neusoft Medical Systems o Canon Medical Systems Corporation

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snippet, By Technology  Market Snippet, By Disease Indication  Market Snippet, By End User  Market Snippet, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  PEST Analysis  PORTER’s Five Forces Analysis  Market Opportunities  Regulatory Scenario  Key Developments  Industry Trend 4. Global Neurological Disorder Diagnostics Market, By Technology, 2026-2033, (USD Bn) o Introduction  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Imaging  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o In Vitro Diagnostics  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends 5. Global Neurological Disorder Diagnostics Market, By Disease Indication, 2026-2033, (USD Bn) o Introduction  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Genetic Neurological Disorders  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Immunological Neurological Disorders  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Paraneoplastic Syndrome  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Paraproteinemic Neuropathies  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Others  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends 6. Global Neurological Disorder Diagnostics Market, By End User, 2026-2033, (USD Bn) o Introduction  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Hospitals & Clinics  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Diagnostics Centers  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Ambulatory Care Centers  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends 7. Global Neurological Disorder Diagnostics Market, By Region, 2026-2033, (USD Bn) o Introduction  Market Share Analysis, By Region, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, For Region, 2021 - 2033 o North America  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Technology, 2026- 2033, (USD Bn)  Market Size and Forecast, By Disease Indication, 2026- 2033, (USD Bn)  Market Size and Forecast, By End User, 2026- 2033, (USD Bn)  Market Size and Forecast, By Country, 2026- 2033, (USD Bn) o U.S. o Canada o Latin America  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Technology, 2026- 2033, (USD Bn)  Market Size and Forecast, By Disease Indication, 2026- 2033, (USD Bn)  Market Size and Forecast, By End User, 2026- 2033, (USD Bn)  Market Size and Forecast, By Country, 2026- 2033, (USD Bn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Technology, 2026- 2033, (USD Bn)  Market Size and Forecast, By Disease Indication, 2026- 2033, (USD Bn)  Market Size and Forecast, By End User, 2026- 2033, (USD Bn)  Market Size and Forecast, By Country, 2026- 2033, (USD Bn) o U.K. o Germany o Italy o France o Spain o Russia o Rest of Europe o Asia Pacific  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Technology, 2026- 2033, (USD Bn)  Market Size and Forecast, By Disease Indication, 2026- 2033, (USD Bn)  Market Size and Forecast, By End User, 2026- 2033, (USD Bn)  Market Size and Forecast, By Country, 2026- 2033, (USD Bn) o China o India o Japan o ASEAN o Australia o South Korea o Rest of Asia Pacific o Middle East  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Technology, 2026- 2033, (USD Bn)  Market Size and Forecast, By Disease Indication, 2026- 2033, (USD Bn)  Market Size and Forecast, By End User, 2026- 2033, (USD Bn)  Market Size and Forecast, By Country, 2026- 2033, (USD Bn) o GCC Countries o Israel o Rest of Middle East o Africa  Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033  Market Size and Forecast, By Technology, 2026- 2033, (USD Bn)  Market Size and Forecast, By Disease Indication, 2026- 2033, (USD Bn)  Market Size and Forecast, By End User, 2026- 2033, (USD Bn)  Market Size and Forecast, By Country, 2026- 2033, (USD Bn) o South Africa o North Africa o Central Africa 8. Competitive Landscape o Heat Map Analysis o Market Share Analysis (3x3 Matrix) o Company Profiles  Siemens Healthineers o Company Overview o Product Type Portfolio o Recent Developments/Updates  Koninklijke Philips N.V. o Company Overview o Product Type Portfolio o Recent Developments/Updates  General Electric Company o Company Overview o Product Type Portfolio o Recent Developments/Updates  Esaote SpA o Company Overview o Product Type Portfolio o Recent Developments/Updates  NeuroLogica Corporation o Company Overview o Product Type Portfolio o Recent Developments/Updates  Masimo Corporation o Company Overview o Product Type Portfolio o Recent Developments/Updates  York Instruments Ltd. o Company Overview o Product Type Portfolio o Recent Developments/Updates  Neusoft Medical Systems o Company Overview o Product Type Portfolio o Recent Developments/Updates  Canon Medical Systems Corporation o Company Overview o Product Type Portfolio o Recent Developments/Updates 9. Analyst Recommendation o Wheel of Fortune o Analyst View o Coherent Opportunity Map 10. Section o References o Research Methodology o About Us and Sales Contact

提及公司

Siemens HealthineersKoninklijke Philips N.V.General Electric CompanyEsaote SpANeuroLogica CorporationMasimo CorporationYork Instruments Ltd.Neusoft Medical SystemsCanon Medical Systems Corporation

同分類最新報告（醫療與生命科學）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們